Cirrus Healthcare improves upon its best-selling EarPlanes with launch of EP2

COLD SPRING HARBOR, N.Y. — Earlier this year, Cirrus Healthcare Products improved upon what was already one of the leading earplugs on the market with the introduction of EP2 at a suggested retail price of about $10.



Its predecessor, EarPlanes, generated $3 million across total U.S. multi-outlets for the 52 weeks ended July 10, according to IRI, on growth of 3.9%.



"After years of Earplanes user requests for a reusable,softer [earplug] and a safety tether for child safety, Adult and Childrens EP2 was released to the market," Drew O'Connell, CEO Cirrus Healthcare, told Drug Store News. "User experience to date has been very positive."



Cirrus Healthcare is both the pioneer and patented inventor of Earplanes, raising awareness across both consumers groups and doctors that a solution to ear barotrauma was available. "Today, Earplanes is the gold standard in flight protection globally," O'Connell said.



In addition to including a convenient tether, the improved EP2 earplugs are reusable for up to 10 trips.